Patent details

EP2303912 Title: CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME

Basic Information

Publication number:
EP2303912
PCT Application Number:
JP2009002771
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP097664403
PCT Publication Number:
WO2009153992
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
French Title of Invention:
PEPTIDES D ÉPITOPE DE CDCA1 ET VACCINS CONTENANT CEUX-CI
German Title of Invention:
CDCA1-EPITOP-PEPTIDE UND IMPFSTOFFE, DIE DIESE ENTHALTEN
SPC Number:

Dates

Filing date:
18/06/2009
Grant date:
03/01/2018
EP Publication Date:
06/04/2011
PCT Publication Date:
23/12/2009
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/01/2018
EP B1 Publication Date:
03/01/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/06/2018
Expiration date:
18/06/2029
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/12/2017
 
 

Name:
Oncotherapy Science, Inc.
Address:
2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, Japan (JP)

Inventor

1

Name:
YOSHIMURA, Sachiko
Address:
Japan (JP)

2

Name:
OHSAWA, Ryuji
Address:
Japan (JP)

3

Name:
TSUNODA, Takuya
Address:
Japan (JP)

Priority

1

Priority Number:
74062 P
Priority Date:
19/06/2008
Priority Country:
United States (US)

2

Priority Number:
197599 P
Priority Date:
28/10/2008
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/00; A61K 39/00; C07K 14/47; C12N 5/0783;

Publication

European Patent Bulletin

Issue number:
201801
Publication date:
03/01/2018
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
30/10/2018 Outgoing Correspondence 1